Concepedia

Author

Craig Leonardi

Boehringer Ingelheim (Canada)

Also Known As

C Leonardi, C. Leonardi, Carla Leonardi, Craig Leonardi, Craig T Leonardi

36

Publications

255

Citations

8

H-Index

17

Concepts

All Affiliations

Boehringer Ingelheim (Canada)
CL

About

Craig Leonardi is an author at Boehringer Ingelheim (Canada) specializing in medicine, dermatology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

89

2

Pharmacology

2

2

71

3

Immunology

1

1

23

4

Molecular Biology

1

1

18

5

Autoimmune Disease

1

1

23

Craig Leonardi

×

6

Publications

202

Citations

6

H-Index

YearCitations

A phase I/II randomized, double‐blind, placebo‐controlled, dose‐ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis

Craig Leonardi, RR Stoltz, PF Pierce,

Journal of the European Academy of Dermatology and Venereology

2005

71

Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris.

Joel Schlessinger, Alan Menter, Michael H. Gold,

PubMed

2007

48

Safety and Tolerability of Ixekizumab: Integrated Analysis of Injection-Site Reactions from 11 Clinical Trials.

Neil H. Shear, C. Paul, Andrew Blauvelt,

PubMed

2018

23

Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials.

Kim Papp, Jennifer Cather, Craig Leonardi,

PubMed

2016

22

The Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2)

Alan Menter, Nehal N. Mehta, Mark Lebwohl,

Journal of Drugs in Dermatology

2020

20

A Molecular Approach to Alopecia Areata

Robert B. Skinner, William H. Light, Craig Leonardi,

Journal of Investigative Dermatology

1995

18

Page 1